We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Biotech / MedicalGMXX - GENEMAX CORP

Previous 10 Next 10 
To: tonto who wrote (932)12/18/2004 1:11:17 PM
From: scion
   of 978

To: TheTruthseeker who wrote (88832) 12/18/2004 12:05:16 PM
From: scionist Read Replies (1) of 88852

Message 20869325



10. Plaintiff Mark F. Backhaus purchased shares of Streamedia common stock pursuant to the Company’s Prospectus filed in connection with its IPO, which was commenced on December 22, 1999. His signed certification, executed pursuant to the federal securities laws, is attached hereto.

11. Streamedia is a Delaware corporation that claims to provide website owners and content publishers with cost-effective services and tools for streaming, or broadcasting, live and on demand video and audio content over the Internet. The Company also operates a so-called .broadcast content website,. Bijou Cafe, at The Company claims to have two primary components: it acts as an Internet content publisher and broadcaster, and as a business-to-business service bureau, to assist other businesses to publish and broadcast their content on the Web.

12. Defendant James D. Rupp ("Rupp") was the President and Chief Executive Officer and a director of the Company from its inception until October of 2000, when he resigned his management role, though he continued to serve as a director. In addition, Rupp signed the Prospectus filed in connection with the Company’s IPO. Rupp has been President and CEO of Capital Markets Communications Corporation a publisher of a number of Internet micro-cap stock
promotion newsletters including StreetSignals, TradeSignals, PowerSignals, AmexWire and the Waaco Kid.s Forum, among others.

13. Defendant Gayle Essary (.Essary.) was a founder, the Chairman and Vice President of the Company from its inception until his termination by the Company in March of 2001. In addition, Essary signed the Prospectus filed in connection with the Company’s IPO. Essary has also been Chairman of Investors Research Institute, an organization aimed at promoting the stock of microcap companies to individual investors. He is, and has been, an executive officer of several other companies that operate Internet stock promotion newsletters including HotStocks@StreetLevel, the Waaco Kid.s Forum and a number of others.

14. Defendant Walter Hollenberg ("Hollenberg") was the Vice President of Technology for Streamedia from July 1999 until sometime in 2000 and is listed in the Prospectus as an executive officer of the Company.

15. Defendant Nicholas Malino ("Malino") was the Chief Financial Officer of the Company beginning in November of 1998 and also served as Executive Vice President and Chief Operating Officer from August of 1999 until his resignation in October of 2000. In addition, Malino signed the Prospectus filed in connection with the Company’s IPO.

16. Defendant Henry Siegel (.Siegel.) was at all relevant times a director of the Company and in October of 2000, Seigel became the Chief Executive Officer of the Company. In addition,
Seigel signed the Prospectus filed in connection with the Company’s IPO.

17. Defendants Robert J. Wussler and David J. Simonetti were, at all relevant times, directors of Streamedia, and they each signed the Prospectus filed in connection with the Company’s IPO.

18. For purposes of this Complaint, the individual defendants identified in ¶¶12-17 shall be referred to herein as the "Individual Defendants."

19. Defendant Capital West Securities, Inc. (.Capital West.) is an Oklahoma corporation principally located at 211 North Robinson Street, Suite 200, Oklahoma City, OK, 73102-7101. Capital West is an NASD registered broker/dealer and acted as a lead underwriter and as corepresentative
for the underwriting group in the IPO.

20. Defendant Institutional Equity Corporation (.IEQ.) is an Oklahoma corporation principally located at 5910 North Central Expressway Ste. 1480, Dallas, TX 75206. IEQ is an NASD registered broker/dealer and acted as a lead underwriter and as co-representative for the underwriting group in the IPO.

21. Defendant Kashner Davidson Securities Corporation (.Kashner.) is a Florida corporation principally located at 77 South Palm Avenue, Sarasota, FL 34236-7724. Kashner is an NASD registered broker/dealer and acted as an underwriter for the IPO.

22. Defendant Nutmeg Securities, Ltd. (.Nutmeg.) is a Connecticut corporation principally located at 495 Post Road East, Westport, Ct 06880. Nutmeg is an NASD registered broker/dealer and acted as an underwriter for the IPO.

23. Defendant Schneider Securities, Inc. (.Schneider.) is a Colorado corporation principally located at 1120 Lincoln Street, Suite 900, Denver, CO, 80203. Schneider is an NASD registered broker/dealer and acted as an underwriter for the IPO.

24. Defendant Westport Resources Investment Services, Inc. (.Westport.) is a Connecticut corporation principally located at 315 Post Road West, Westport, CT 06880-4645. Westport is an NASD registered broker/dealer and acted as an underwriter for the IPO.

25. Defendant The Agean Group, Inc. (.Agean.) is a Florida corporation principally located at One South Ocean Blvd. Suite 300, Boca Raton, FL, 33432. Agean is an NASD registered broker/dealer and acted as an underwriter for the IPO.

26. Defendant Smith, Moore & Co. (.Smith.) is a Missouri corporation principally located at 400 Locust Street, St. Louis, MO 63102. Smith is an NASD registered broker/dealer and acted as an underwriter for the IPO.

27. Defendant Global Capital Securities Corporation, formerly known as EBI Securities Corporation (.Global.) is a Missouri corporation principally located at 6300 South Syracuse Way, Suite 645, Englewood, CO, 80111. Global is an NASD registered broker/dealer and acted as an underwriter for the IPO.

28. For purposes of this Complaint, defendants Capital West, IEQ, Nutmeg, Kashner, Westport, Schneider, Agean, Smith and Global will be referred to herein as the "Underwriter Defendants."

29. The Underwriter Defendants were the underwriters for the IPO, and were primarily involved in offering and selling shares of the Company to the public in the IPO.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)

To: scion who wrote (933)12/18/2004 1:16:09 PM
From: tonto
   of 978
They forgot to mention that he claimed he was a confidante of LBJ too...(g) He had this bathroom story that he liked to tell...

Share RecommendKeepReplyMark as Last ReadRead Replies (1)

To: tonto who wrote (934)12/18/2004 1:32:32 PM
From: scion
   of 978
Essary seems to have been a "confidante" of many people....maybe he sees himself as "inside the tent..."

Share RecommendKeepReplyMark as Last ReadRead Replies (2)

To: scion who wrote (935)12/18/2004 1:41:05 PM
From: tonto
   of 978
lol. Essary would talk big through his "media empire", but then would cry about his old beater that he had to drive and he did not want his children to learn through the internet what he truly is...

Share RecommendKeepReplyMark as Last Read

To: afrayem onigwecher who wrote (931)12/29/2004 10:46:57 AM
From: StockDung
   of 978
.IN THE MONEY: GeneMax Naked-Short Suits Dismissed

28 December 2004
Dow Jones News Service
(c) 2004 Dow Jones & Company, Inc.

By Carol S. Remond
A Dow Jones Newswires Column

NEW YORK (Dow Jones)--Two more lawsuits alleging illegal short selling
by brokerage firms have been dismissed without much fanfare.

Biotech company GeneMax Corp. (GMXX) was at the forefront of companies
protesting what they said were unfair attacks by short sellers in late
2002. Back then and through much of 2003, GeneMax and its then-marketing
firm Investor Communications International, or ICI, led a campaign
against naked short selling, or short selling without first borrowing
securities to make delivery.

As part of its campaign, GeneMax filed lawsuits in Canada and in the
U.S. to try to prevent brokerage firms from engaging in naked short

GeneMax filed a lawsuit against Canadian brokerage firms Global
Securities Corp. and Union Securities Corp. in September 2002 in the
Supreme Court of British Columbia. The company alleged that the
brokerages engaged in illegal short selling to manipulate the price of
its shares.

A court order obtained by Dow Jones Newswires shows that suit was
dismissed on Dec. 16. A countersuit filed by Global Securities and Union
Securities was also dismissed.

GeneMax had widened its legal fight with the brokers to U.S. courts in
October 2002 when it filed suit against 11 brokerage firms in the U.S.
District Court for the District of Nevada. That suit was dismissed. But
the company filed another suit in November 2003 that mirrored much of
the illegal short selling allegations it made in its first Nevada suit,
including fraud and racketeering. The original suit named Knight Trading
Group Inc. (NITE), Charles Schwab Corp. (SCH) and nine others and seeks
injunctions to prevent the firms from shorting GeneMax shares and
unspecified damages.

Court documents show that the 2003 Nevada suit was dismissed on Nov. 9.

GeneMax's shares, which topped $20 a share in late 2002, are now trading
at a mere 24.5 cents in very thin trading.

GeneMax's President and Chief Executive Ronald Hanford wasn't
immediately available to comment.

GeneMax was the subject of three "In The Money" columns in 2002 and
2003. Those columns questioned whether insiders would benefit most from
limits on short selling and GeneMax's connection to consultant ICI.
GeneMax terminated its agreement with ICI in late 2003.

In a short sale, a security not owned by the seller is sold in
anticipation of a decrease in the stock's price. In the U.S., NASD
requires that before they engage in short sales for themselves or
clients, firms make an affirmative determination that they can borrow a
security or will be able to provide it for delivery on demand. Market
makers are exempt from the affirmative determination rule when engaged
in "bona fide market making activity" because they provide needed
liquidity to the market. Earlier this year, NASD tightened its
affirmative determination rule, making it harder for Canadian brokerages
to take advantage of the fact that no borrowing requirement exists in
that country.

In September, another suit alleging naked short selling was dismissed
after Jag Media Holdings Inc. (JAGH), which also led the charge against
naked short selling in the U.S., failed to make its case.

Jag Media and Gary Valinoti, the company's former chief executive, sued
more than 100 brokerage firms, investment firms and financial
institutions in July 2002, alleging that they entered into a civil
conspiracy and concert of action to short sell Jag Media's stock. In the
suit, originally filed in the Judicial District Court, Harris county in
Texas and later removed to the U.S. District Court for the Southern
District of Texas, Houston Division, Jag Media alleged that the
financial institutions committed market manipulation and fraud and
violated securities laws.

That case was dismissed by U.S. District Judge Vanessa Gilmore after she
found multiple deficiencies in Jag Media's third amended complaint.
Gilmore found that Jag Media didn't have a viable claim against those

(Carol S. Remond is an award-winning columnist and one of four who write
the "In The Money" feature. Most recently, she shared a 2003 Best of
Business Award from the Society of American Business Editors and Writers
for her role in Dow Jones' team coverage of the Canary Capital mutual
fund trading scandal.)

-By Carol S. Remond; Dow Jones Newswires; 201 938 2074; [ 12-28-04 1742ET ]


Share RecommendKeepReplyMark as Last Read

To: afrayem onigwecher who wrote (931)12/29/2004 11:37:31 AM
From: StockDung
   of 978

"In this respect, it is suggestive that the SEC apparently leaked its complaint about Agora to Remond, who cooperated by writing a story trumpeting the SEC's effort to discredit me and these good companies."

Dear Vantage Point Investor,

You may be as startled and upset as I am by the sudden collapse in the price of GeneMax (GMXX), which has tumbled in the last nine trading days. The question is, why? I can't pretend that I fully understand the answer. But I have a disturbing guess. It appears that the naked short-sellers who have counterfeited millions of GeneMax shares in an attempt to destroy the company have enlisted powerful help.

In theory, the Securities and Exchange Commission is a regulatory body charged with maintaining the integrity of public securities markets in the United States. In reality, the SEC is like any other government agency. It responds to powerful entrenched interests. It abhors bad publicity, rewards its friends and punishes its critics.

Unhappily, the SEC also lies. I know because the SEC field office in Utah has lied about me. And I suspect that these lies are the culmination of a carefully laid plan to discredit GeneMax and punish the company for raising troublesome issues about naked short selling, which has also embarrassed the SEC.

If you have been a subscriber to Vantage Point for any length of time, you are no doubt aware that I am a critic of "electronic counterfeiting," the process by which some investment banks, market makers and broker-dealers drive down the prices of Nasdaq Bulletin Board companies by selling unlimited quantities of shares they don't own. Since stock prices are determined by supply and demand, allowing unlimited counterfeiting of stock essentially guarantees that the stock becomes worthless.

Of course, a company whose shares are worthless won't last long. It is unable to raise money if its stock is worthless. All too often, such small companies are driven into oblivion by electronic counterfeiting. When we are slogging along with a weak economy, I consider it almost criminal negligence that the government would permit investment banks, market makers and broker-dealers to weaken the economy further by destroying small companies that could otherwise be a major fountain of growth.

Why would the government let this happen? I don't think it is necessarily a Grand Conspiracy with a capital "G." But the bad guys have managed to control most of the news about "electronic counterfeiting." And perversely, they also seem to have the regulators on their side.

I had a painful lesson in this reality at the beginning of this week when I learned to my astonishment that the Utah office of the SEC had tarnished my name by accusing me of failing to disclose an interest in two investments that I recommended in Vantage Point Investment Advisory. Their exact charge is as follows:

"Among the issuers promoted in this manner have been GeneMax Corp. and Endovasc Ltd., Inc. DAVIDSON is an officer, director and, indirectly, a substantial shareholder of these two issuers. Neither the soliciting e-mail nor the subsequent company report discloses DAVIDSON's relationship to the companies."

This is total rubbish. I deny any impropriety. Indeed, the charges are remote from the facts.

As you will know if you subscribed to Vantage Point last summer, I fully disclosed my role as a founder, director and officer of GeneMax when I recommended the company and its promising treatment for cancer. And I also disclosed a special relationship with Endovasc. I am not an officer or director of Endovasc. I have a few shares that I received in exchange for assigning my rights in what could be a valuable patent to the company.

To be sure that I wasn't missing something, I had my attorney review the record. He concluded that my disclosures are complete: "I spent this afternoon reviewing Agora marketing copy for Vantage Point and the newsletters and have verified that the charge that you failed to disclose your personal interest in GeneMax is completely false." Agora will be filing a motion to dismiss the SEC's baseless complaint.

I fail to see how anyone of good faith who reviewed the record could possibly construe it as the SEC apparently has. Although I can't prove it, I have concluded that the SEC, or at least some of its personnel, were more offended by my criticism of electronic counterfeiting than they are by the abuse itself -- which causes you and other investors hundreds of billions in losses. In fact, the costs of electronic counterfeiting are much higher than those entailed in the accounting scandals which have garnered so much attention. Nonetheless, instead of correcting these abuses, the SEC has gone out of its way to rope me into a doubtful complaint that they have developed against another Agora publication -- a product to which I have no connection other than a passive one as a minority shareholder in Agora.

Nor do I take it to be entirely a coincidence that while I have recommended more than 30 investments in Vantage Point over the past 16 months, my reputation is being tarred in respect to just two companies, GeneMax and Endovasc. These two companies have one thing in common, in addition to the fact that both have promising medical innovations that could ease much suffering and save many lives. Both have been at the forefront of legal action to combat the abuse of electronic counterfeiting of their shares. But these efforts have hardly earned them the friends they should. Rather than garnering applause, their efforts to confront the abuse of electronic counterfeiting of their shares has made both companies the focus of negative publicity.

In particular, one writer, Carol S. Remond, undertook to paint a negative picture of both companies, publishing what bordered on outright lies. For some reason known only to others, the SEC appears to have adopted Remond's text in defense of the electronic counterfeiters. In this respect, it is suggestive that the SEC apparently leaked its complaint about Agora to Remond, who cooperated by writing a story trumpeting the SEC's effort to discredit me and these good companies.

I wanted to write to you immediately when I got this startling news to tell you that I will not be cowed by these Machiavellian tactics. I will continue to raise important issues of investor protection that the SEC appears to wish to duck. I do so with faith that the truth will eventually triumph, the evil of electronic counterfeiting will be curtailed, and the integrity of public security markets restored.

Or to put it another way, if powerful people are so keen to discredit my criticism of electronic counterfeiting that they will orchestrate an entirely bogus charge of the kind carried on the wires against me this week, that itself indicates that more light needs to be shed on the shadowy activities they are trying to protect.

But, on to the status of your GeneMax holdings... Absolutely nothing about this company or its exciting immunotherapy development has changed and would warrant this share price decline. In fact, in an independent study commissioned by the company, it was determined that if GeneMax were funded as low as at $1.50 per share, and assuming that its products prove to work as well in humans as they have in animals, the present value of the stock would be $420 per share, notwithstanding dilution. GeneMax remains a fundamentally sound company and a tremendous buying opportunity at these levels. I recommend that you increase your GeneMax shares, as well as those in Endovasc (EVSC.OB). And, may I reiterate, I am a shareholder in both companies.

And, if you are as concerned as I am about electronic counterfeiting and its effects on the dynamic young companies that must fuel our country's future growth (as well as your portfolio), I urge you to write your congressman. You can also register your concern with the National Association Against Naked Short Selling (,, which is taking up the fight for companies and investors alike.



Share RecommendKeepReplyMark as Last Read

To: scion who wrote (935)3/5/2005 3:44:55 PM
From: StockDung
   of 978
BCSC not pursuing Nano World ex Hunter

2005-03-04 14:25 ET - Street Wire

by Stockwatch Business Reporter

The B.C. Securities Commission, in its pending hearing for Nano World Projects Corp. and its president, Robert Papalia, is not pursuing former Nano World president David Hunter. Mr. Papalia blamed Mr. Hunter for landing the company in trouble with the U.S. Securities and Exchange Commission and even sued him in B.C. Supreme Court.

The BCSC goes after Nano World

The BCSC has scheduled a hearing for March 7 to try Mr. Papalia and Nano World for allegedly pumping the company with misleading news. The local regulator says Mr. Papalia and Nano World misled investors with false news releases claiming the company had two big deals in Europe.

Nano World, at the time, traded on the lightly regulated, but heavily prosecuted OTC Bulletin Board.

According to the BCSC, Mr. Papalia began issuing the misleading news releases on Sept. 12, 2000, in which he touted deals with Italian automotive giant Fiat and printing company Euroinks (pronounced Euro-inks, not Eur-oinks).

To back up these purported deals, the BCSC says Mr. Papalia issued further news claiming another OTC-BB company, Frefax Inc., was going to provide a loan.

The BCSC alleges that Mr. Papalia sold at least 300,000 shares of Nano World between January and February, 2001, for proceeds of up to $130,000.

The SEC goes after Mr. Papalia

The BCSC was not the first regulator to target Mr. Papalia for the Nano World promotion. The SEC, in a civil action, won a permanent ban against Mr. Papalia on Sept. 1, 2004, for his Nano World shenanigans.

In that case, Judge Marsha Pecham of the United States Federal District Court in Seattle found that Mr. Papalia pumped Nano World up to $24.50 using misleading or false news releases.

In a 15-page judgment she said, "Papalia's violation involved fraud, deceit, manipulation, or deliberate and reckless disregard of a regulatory requirement." In addition to the permanent ban, Judge Pecham fined Mr. Papalia $33,000.

Mr. Papalia, in a statement of defence, denied the SEC's accusations.

The SEC goes after Mr. Hunter

The SEC also named Mr. Hunter in the same civil action as Mr. Papalia. The U.S. regulator said Mr. Hunter misled Nano World investors with false news releases.

Mr. Hunter, who denied the SEC's allegations, settled with the U.S. regulator out of court. He agreed to a five-year ban from the markets and to an injunction barring future U.S. Securities Act violations. He did not admit to any wrongdoing in reaching the settlement.

Mr. Howe Street

David Hunter -- son of Ben, brother of Dan, father of five -- has spent much of his life up to his eyeballs in penny stocks. Many of them have gone to many dollars, and most have ended back where they began. Although Mr. Hunter has not been accused by the BCSC of any Nano World wrongdoing, Mr. Papalia alleged halfheartedly in a very brief lawsuit that Mr. Hunter was at least partly responsible for the company's trouble.

Mr. Papalia sued Mr. Hunter in B.C. Supreme Court on Aug. 16, 2002, on behalf of Nano World. In his self-filed writ, Mr. Papalia said Mr. Hunter misappropriated Nano World's money.

The case never made it before a judge. Mr. Papalia did not follow up his writ a formal statement of claim, which would have provided details, if not credibility, to the allegations against his former colleague. Mr. Hunter did not file a statement of defence.

Mr. Hunter landed at Nano World 10 days after leaving the Vancouver brokerage industry on March 31, 2000. His 25-year brokerage career began in 1975 and included stints at four Vancouver brokerages.

Mr. Hunter's last job in the brokerage industry was at Mark Valentine's Thomson Kernaghan, which he left on March 31, 2000. Prior to Thomson Kernaghan, Mr. Hunter worked at Canaccord Capital Corp. between Sept. 2, 1992, and Jan. 15, 1996. When David and brother Dan arrived at Canaccord from Yorkton Securities, David said: "Our style is probably more like that of venture capitalists/merchant bankers. We try to identify situations, especially junior industrials, that have merit."

During his years as a big-producing broker, seeking those junior industrials of merit, Mr. Hunter introduced some of the players in Brent Pierce's Ultra Pure Water Systems (Canada) Inc., a promotion that left seven brokerages with $2.36-million in unpaid debits. Stephen Taub, a key broker in the case, said he was introduced to two of Ultra Pure's founders, Louis Gorusch and Grant Atkins, by the Hunters.

Mr. Hunter and his brother were also parties of interest, but not suspects or targets, in the SEC's civil prosecution of Dimples Group Inc., a raucous Vancouver Stock Exchange diaper promotion of the early 1990s that ended up covered like most diapers.

Other enterprises of merit that Mr. Hunter was involved with included Cost Miser Coupons (International) Inc. and, a rare success, PLC Systems Inc.

Mr. Hunter could not be reached for comment on Nano World or any other matters. He was last thought to be in Mexico. Mr. Hunter's lawyer in the U.S. case, John Payseno, said he was too busy to comment on the matter.

The BCSC, for its part, says it is aware of Mr. Hunter's involvement with Nano World.

The commission's hearing against Mr. Papalia and Nano World is set to kick off Monday, March 7.

Share RecommendKeepReplyMark as Last Read

From: StockDung3/22/2005 12:56:56 PM
   of 978
A Silver Bullet That Conquers Nature's Deadliest Disease Is
About to "Go Public"

Now There Is Only a Brief Window -
Perhaps Just Weeks - Before These
Shares Blast Off

Dear Reader,

A small U.S. company - already raking in revenues of more than $1 billion and showing net profits of over $150 million - will post explosive gains in both sales and profits in the weeks ahead. Those who own the stock are - in effect - holding a winning lottery ticket.

1.3 million Americans are diagnosed with cancer each year. And, sadly, more than 1,500 people in the U.S. die from it every day.

But one company is doing something about it. No... not a biotech company hoping to make it through Phase III trials, but rather a medical technology firm whose products are actually killing cancer tumors right now in hundreds of hospitals around the world.

How? With a new cutting-edge technology only recently unveiled. And investors who hold this stock are ready to collect the payoff of a lifetime.

Just listen to what the experts have to say about this company's technology:

* The medical director at the Alta Bates Comprehensive Cancer Center in Berkeley, California says "a quarter or possibly a third of our cancer patient population will soon be undergoing this treatment."
* Another prominent doctor at the University of Texas M.D. Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology. And, he adds, "it is very much a part of our future."
* And the Professor of Oncology at the University of Michigan, says this breakthrough technology has opened up nothing less than "extraordinary possibilities."

Yet most folks on Wall Street are still unaware of this story. Few investment firms even follow the stock.

But it's just a matter of time before the national media seizes on what's happening here... and turns this unknown company into a household name. Then millions of individual investors - and their fund managers - will begin shoveling money into the stock.

When the public finally understands this company is actually killing cancer tumors right now with a success rate as high as 96%, shares of this company will simply ignite. And, quite frankly, there is no calculating how high the stock will go.

"When the public finally understands this company is actually killing cancer tumors right now with a success rate as high as 96%, shares of this company will simply ignite."
Even the U.S. government has given this new technology its blessing. How can we be sure? Because the company's cancer treatments have just become eligible for both Medicare and Medicaid reimbursement.

Before long, cancer patients the world over will be demanding this medical treatment. And that will spark interest in the stock by investors all over the globe.

That's why I'm contacting you now.

The Sound of Opportunity Knocking . . .

My name is James Boxley Cooke. I'm a former executive of T. Rowe Price.

I'm retired and no longer in the mutual fund business, however. Today I serve as the Chairman of the Board of Governors of the world's largest private financial fellowship. And, quite frankly, my position as head of one of the world's most powerful investment groups gives me access to intelligence and ideas the average investor never hears about.

Our results are nothing short of stellar. Of the 35 current positions in our Trading Portfolio, 29 are profitable, for example.

And recently some members have taken the opportunity to lock in phenomenal short-term profits. Just a brief sampling of our recent winners include:

* 293% in nine weeks in a company that makes nutritional supplements for infant formula.
* 222% in four months in the world's largest web-based auctioneer.
* 433% in ten weeks in an Israeli manufacturer of generic pharmaceuticals.
* 485% in seven weeks in a conservative educational publisher.
* 296% in 27 days in a private, post-secondary education company.
* 180% in two weeks in a leading prison privatization company.
* And 1,385% in a diversified information management systems company. (That's right. Our investment rose more than thirteen-fold in just three months.)

I need hardly remind you that the market's return this year has been a small fraction of this.

Our secret? My group's gains are the result of private connections and top-notch investment intelligence. This allows us access to a steady supply of unusual and highly profitable investment opportunities. But none surpasses the potential of the medical technology company I'm going to tell you about now.

If your portfolio has been damaged by the bear market of the last three years - or you feel like your investments are just treading water - take heart. Because this opportunity has the potential to create life-changing results for you and your family.

This medical technology company meets every one of our criteria for phenomenal returns: cutting-edge products, soaring revenues, blockbuster earnings growth and an enormous new market for its products.

This, in fact, may be the best single-stock opportunity I've seen in my lifetime as an investor. And I've been in the business for over 45 years.

That's why I'm contacting you now. Because if time was ever of the essence, it's now...

Why Early Investors Will Make a Fortune

Let me begin by showing you the immense potential behind this groundbreaking medical technology.

$60 billion is spent on cancer treatment in the U.S. each year. That's right... each year.

Cancer is our country's most notorious killer. There is not a family in this nation that has not been touched in some way by this dreaded disease.

The American Cancer Society estimates that 1.2 million new cancer cases are diagnosed each year. And the total number of cancer cases rises 3% a year in this country.

You don't have to be Isaac Newton to figure out that with baby boomers steadily aging - and increasing their susceptibility to cancer - this company's future growth is assured.

The company is already growing by leaps and bounds right now. That's because this life-saving technology is being used to treat cancers of the head and neck, prostate cancer, pancreatic cancer, spinal cancer, throat cancer, uterine cancer and non-Hodgkin's lymphoma.

There is well-founded speculation that the company may soon get FDA approval to treat breast and lung cancer as well. When it does - and I'm expecting an announcement any day now - it's going to look like the Fourth of July.

Killing Cancer... And Making a Killing Too

If your first instinct is to think, "this stock must be headed for the moon," I couldn't agree more. In fact, the company is already making millions for shareholders.

That's because this company is indisputably the world's best at treating - and killing - cancerous tumors. And despite the firm's enormous profit margins, there isn't a single company in the U.S. that poses a competitive threat. Not one.

And there won't be, either. The company's products - built exclusively with state-of-the-art medical technology - cost $1.7 million each.

Why so much?

Their patented system uses digital technology and computer-generated images to aim powerful radiation beams at cancerous tumors. Unlike traditional radiation therapy, however, this company's system avoids damaging healthy organs and tissue near the tumor. And the company's products are so precisely engineered that they can sculpt beams to fit specific areas, as well as modulate the intensity of the beams for different types of tumors.

Very soon the company will unveil an upgrade to existing technology that will even let radioactive beams adjust to body movements as a patient breathes. It's that precise.

"Already the company's profit growth puts it in the top 2% of all publicly traded companies in the U.S."
The intense regulation of the healthcare industry, the complexity of the technology and the cost of the machines - which can only be produced at $1.7 million each when manufactured in huge quantities - have formed a protective moat around this company.

That means a lot to us as early investors. Because it means our investment is safe. And our profits are secure.

Already the company's profit growth puts it in the top 2% of all publicly traded companies in the U.S. And with a current order backlog of more than $900 million, things are set to get a whole lot better.

Because of continued strong demand for the company's oncology products, earnings will soar in the weeks and months ahead.

But there is yet another important reason to own this stock right now. The company is about to get an additional kicker from the Department of Homeland Security.

This Company Defeats Cancer... And Terrorists Too

On a personal level, the biggest threat we face as individuals is a cancer diagnosis.

But - as you know - on a national scale, we face a far bigger threat: terrorist acts designed to kill hundreds or perhaps thousands of innocent people. After 9/11 - and with the advent of the Department of Homeland Security - millions of dollars will be paid to those with the proven ability to prevent such attacks. Incredibly, this medical technology company is doing just that - preventing terrorist attacks - right this minute. And has a 100% success rate.

The same breakthrough medical technology that allows this company's products to see inside your body, also allows inspectors to see through 17 inches of steel.

According to the U.S. Customs Service, 6 million cargo containers arrive through 361 U.S. seaports each year. Ninety percent of the trade goods brought into the U.S. each year - some 2 billion metric tons worth - enter the country this way.

"This company has invented a "silver bullet" that defeats cancer and foils terrorist attacks."
And less than 2% of the containers are ever opened and inspected by Customs Service officials.

It's not hard to imagine these containers being used for smuggling contraband - even a potential weapon of mass destruction. Yet to physically open each container, extract the contents, and inspect the contents by hand would be time-consuming and unrealistic.

Be Sure to Register for The Investment U E-Letter

In Just 20 Minutes a Week You Can Become
More Market Savvy than 99% of Investors

Register here for your FREE Investment U online advisory. The Investment U E-Letter will help you beat the markets and stay on the path to financial independence. Twice weekly, renowned editor Dr. Steve Sjuggerud uncovers hidden market indicators, time-tested investing techniques and current emerging trends. You get action-oriented, reliable advice that will make you a smarter investor--fast. You have nothing to lose - but a wealth of proven, effective investment secrets to gain. There is no obligation. You can begin your FREE subscription to The Investment U E-Letter by entering your e-mail address below and clicking "Subscribe".

Investment U will never sell, rent or otherwise abuse your email address. It will be used solely for the purpose of sending you the Investment U E-Letter and Updates about Investment U. Should you wish to unsubscribe at any time, instructions are included with each email for immediate removal from the Investment U E-Letter subscriber file.
Not to mention unnecessary. Because this same medical technology company has developed a product that works like a giant airport baggage screening system. And can generate steel-piercing X-rays that see through container walls and allows contraband nowhere to hide.

At heart, the technology is quite simple. Electronic images are captured and transmitted to a computer monitor at an operator's station. The machine can scan a full container the size of a tractor trailer in less than three minutes. In short, it's practical, efficient and cost-effective.

The Department of Homeland Security may soon come knocking on their door with a major order. And that will turn this smaller part of their business into something very big. The effect on the stock should be tremendous.

If this firm gets a major defense-related contract, the stock will gap up immediately.

And that could happen at almost any time. Right now we have a gaping hole in national security. Dockworkers know it. Terrorists know it. So do U.S. government officials.

The head of Homeland Security, and President Bush are not going to let this vulnerability continue. And, fortunately, Congress is willing to put up the money to guarantee it.

With this company's products already screening cargo in one U.S. port and dozens of others around the world, it's my belief that it's only a matter of time before they're tapped for the big national security job.

When management reports that the company's products have been chosen by the federal government to help provide security at the nation's seaports, the stock won't just rise. It will look like something coming off the launch pad at the Kennedy Space Center.

Let me emphasize that this announcement has not been made yet.

However, I believe it will be in the coming weeks. That's why I'm sending you this letter today. So you have a chance to profit, along with the rest of the members of our financial fellowship.

Crucial Intelligence... Enormous Profits

Let me put this special opportunity in perspective.

Maybe once in a generation a company comes along that is not only wildly successful, but actually changes our way of life.

Forty years ago, it was IBM. Thirty years ago, it was Wal-Mart. And nearly twenty years ago, it was Microsoft.

"When management reports that the company's products have been chosen by the federal government to help provide security at the nation's seaports, the stock won't just rise. It will look like something coming off the launch pad at the Kennedy Space Center."

Early investors in these companies did not become millionaires. They became billionaires. And even investors who took a very small stake had their financial lives completely transformed.

Now history is repeating itself.

And everything you need to know about this company - which you can quickly buy through your existing broker - is plainly and simply spelled out in our latest special report: "Payoff of a Lifetime: A Company That Fights Cancer & Terrorism Too."

This special "white paper" details all our crucial intelligence on this unique investment opportunity. It's part of a special bonus you'll receive when you sign up for a one-year membership in the investment organization I head, The Oxford Club.

Membership in this club will allow you to receive regular updates on the status of this special investment, as it already tops our list of recommended investments. You'll get regular updates on the stock as your portfolio swells in size. And you'll also learn the proprietary system we use that protects both our profits and our principal on our investments - guaranteed.

However, in joining this well-connected group of investors, you'll receive other benefits you can't put a price on . . .

A "Life-Changing" Experience

The Oxford Club is not another financial newsletter or advisory service. Membership is by invitation only. We're extending this invitation because we have reason to believe you're someone who understands that it's difficult to profit from mainstream advice alone - and that you'd welcome an organization that's independent... unbound by convention and mainstream ideals... and committed to revealing the deeper secrets of creating and growing wealth under any circumstances.

"I am happy with the results of my investments this calendar year (an 83% increase in my portfolio) based solely on The Oxford Club's recommendations."
~ Steve Husbands
The Oxford Club is an organization like no other. And I would like to share with you our substantial intellectual resources, our deep and serious financial network, and our analysts who are diligent and extremely sophisticated. And unlike Wall Street firms, we have no conflicts of interest. We don't do investment banking deals that cloud our objectivity. We don't hawk investments for fees and commissions. We're not interested in "capturing your assets."

Our only obligation is to our members.

As a result, we don't offer an endless stream of "hot tips." Rather, we carefully research thousands of publicly-traded securities to distill the handful of opportunities that are truly worthwhile. And then we group these few winners into one of our select portfolios.

For instance, the medical technology company I'm writing you about is currently #1 in our Oxford Trading Portfolio. This portfolio is made up of the most promising individual securities in the market. Each with a highly unusual story. Each with enormous upside potential.

"About 19 years ago I received an invitation to join The Oxford Club. No one I checked with knew anything about you and I didn't join. In November 2002, I again received an invitation to join. I figured that if you had lasted two decades you couldn't do any worse than all the other investment gurus that helped me lose money. This time I did join and I thank you very much! After one year, EACH of my investments made following your recommendations has been profitable. The Oxford Club is the only investment advisory renewal I have made. In fact, I renewed for life."
~ Henry Rose, Member since 2002

We have other moneymakers as well. Like our Oxford All-Star Portfolio. This portfolio allows you to select investments run by the top money managers on the planet. Who are these individuals? Perhaps you'll recognize a few of their names: Warren Buffett, Bill Gross, Sam Zell, Mark Mobius, Mario Gabelli, Marty Zweig and others. If you don't know these men and their prodigious track records, you'll certainly benefit from getting better acquainted.

And don't overlook our Oxford Income Portfolio. If you're retired, planning for retirement, or just looking to boost your monthly income, you'll be delighted with the jaw-dropping yields we're earning on super safe investments. And without any stock market risk.

We even have a Gone Fishin' Portfolio for members who want to boost their returns while spending as little time as possible fiddling with their investments. This portfolio allows you to beat the market with very little risk, while you spend your time in the shade - casting a purple worm.

Of course, what matters above all else is investment performance, plain and simple. And our returns have been nothing short of spectacular. As we recently wrote to Oxford Club members:

"There are currently thirty-five positions in our Oxford Trading Portfolio. Twenty-nine of them are profitable.

"A considerable satisfaction with portfolio results has allowed me a greater benefit - peace of mind. Since my earned income years are over, this is no small matter. I'm comfortable that my investments are well guided, thanks to you." ~Stephen Fedor
In our Oxford Income Portfolio there are five positions. All of them are profitable.

In our Gone Fishin' Portfolio there are ten positions. All of them are profitable.

In our Oxford All-Star Portfolio there are six positions. One of them is slightly below our original purchase price. When accumulated dividends are included, all of them are profitable.

This is all the more remarkable when you consider the S&P 500 is down 0.69%% year-to-date, and up only 3.59% ove the last 2.5 years."

But there is still more that our group offers. We show you how to save thousands of dollars with your investments, including sensible advice on how to avoid Wall Street's outlandish fees, cut your investment costs to the bone, and eliminate capital gains taxes.

The Most Important Financial Alliance
You Will Ever Make

If such an association appeals to you, I invite you join us. And, of course, begin by receiving our new special report "Payoff of a Lifetime: A Company That Fights Cancer & Terrorism Too."

And please don't overlook the many additional benefits you're entitled to as a new member of The Oxford Club. Here's what you'll soon be receiving:

"The Oxford Club meeting in NYC was excellent. Each of the presenters offered valuable information about the Club and choices we have for protecting and growing our assets. I've paid much more for much less. Truth is, I've attended entire seminars that offered less value than just this 4-hour regional meeting. And the regional meeting was free to members! Another unexpected Oxford Club benefit. Thank you." ~Catherine Wynkoop, Pound Ridge, NY

The Communiqué... the official "letter of record" for Oxford Club members. Twice each month you'll learn about new investments the Club is recommending and get updates on our current portfolio. You'll also be introduced to new investment techniques and strategies - strategies and techniques that will help you become a better, more knowledgeable and wealthier investor. You'll also find wealth-building insights from market experts, traders, and company insiders. One of the most important sections of The Communiqué is the "What To Do With Your Money Today" page, which is a frank and concise discussion about which investments will profit most in the days and weeks ahead. You'll receive The Communiqué the first and fifteenth of every month - plus we'll alert you by e-mail when it's available to members "on line".

"Just a line to thank you for the good recommendations for this year. I am up about 25% for my total assets and over 30% on my assets that were sitting in Money Market accounts. I have learned a lot by being an Oxford Club member. All of the people who contribute are solid analysts. I have taken financial letters for twenty years and never made any money until I came upon the Oxford Club and the talented people on the staff. I do not usually send anyone any thank you messages until now."
~Carlos Tucker
The Communiqué will also keep you apprised of Club happenings, events, meetings and news from our financial network, as well as personal notices from fellow members. In fact, you can place one FREE listing each year yourself. This is an excellent vehicle for buying and selling real estate, finding loans or grants, meeting business partners, getting or offering investment and legal advice, and more.

If The Communiqué were the only benefit you received from the Club you'd be far wealthier because of it. But there's so much more . . .

Members-Only Clubhouses on 3 Continents...
One of the unique privileges of Oxford Club membership is that you always have a "place to visit" when your travels take you near one of our four global locations. There's our U.S. headquarters - a beautifully-restored historic brownstone in the heart of Baltimore's Mount Vernon district.

There's our London office in the bustling Fleet Street district. In Paris you can visit our office on the River Seine, just steps away from Notre Dame Cathedral. Or you can take the train a few hours south to our 17th century château in the French countryside, enjoy authentic French cuisine, walk our miles of tended trails, visit the local towns and take in a wine tour.

For a special treat, you might want to fly down to Central America and spend a few relaxing nights at our brand new members clubhouse retreat located directly on one of the most beautiful beaches you'll find on the Pacific coast. As an Oxford Club member, these clubhouses are yours to use and enjoy.

"I have been receiving solicitations from the OC for many years. All the while my financial advisor and my broker and my pension fund administrators managed to lose a significant portion of my money. So I fired them all and joined The Oxford Club. Hey I figured you could not possibly do worse than them. I admit that I was timid and mistrustful (can you blame me!) at the beginning. Then I started following your recommendations. Lo and behold my investments are actually making, not losing, money. For example I doubled my money on Netflix. I am significantly ahead in all the other recommendations. This is a whole new experience for me. Keep up the good work. And thanks."
~G. Ibrahim, M.D.
Wealth Report Library and Special Investors' Reports... Over the years, The Oxford Club has uncovered many powerful investment techniques and strategies that we feel every member should know about. That's why as soon as you join, we'll send you a library of information that we believe is vital to your financial success - like our report on how to get enormous profits on the best asset class of the last 10 years. There's also a special report on how to trade with the

insiders... another on a strategy many top investors use to trade fast-rising "momentum" stocks... another on the wildly successful covered call strategy we're using to buy stocks cheaper than everyone else... another still on the two most profitable secrets of the world's greatest investors.

Be sure to get all the details on the reports you'll receive on the back of your invitation form I've enclosed for you. But besides your initial library, you can download additional reports from our web site. Everytime we publish a report, we post it to our site for all members to access.

"I have been a subscriber to The Oxford Club for a couple of months now, and recently I subscribed to Steve's Against the Crowd Options service. But the largest returns that I have made up to this point have been from news contained in your Oxford Insight broadcasts. More specifically, the 2 broadcasts highlighting Netflix and Newmont Mining. In both cases, I purchased front month out-of-the-money call options 3-5 days prior to their quarterly earnings announcements, and sold the day after the announcement (in the case of Netflix) or later that same day (in the case of Newmont). With seemingly low risk, my returns were 400% and 200%, respectively!"
~Greg A. Dunsworth

Members Liaison - Pick Up The Phone and Talk to a Research Assistant... Need information on deferring taxes? Want to talk to someone about setting up an offshore account, asset protection plan or privacy strategy? Need information on estate planning? Interested in the safest and most secure way to buy precious metals ... the best and cheapest way to buy stocks on line... how to buy and sell a business? Or do you simply want to have a "real voice" explain one of our professional trading strategies to you? While we can't provide individual financial advice, virtually any financial question you have can be researched on your behalf by one of our member representatives. It's like having your own team of assistants a phone call away!

The Oxford Insight - Real-Time Market Information Directly From Investment Director, Alexander Green, Twice-Weekly... This is one of my favorite benefits of membership because it's a chance for our Investment Director to write directly to members about what's effecting our investments that day. If there's a fast-breaking opportunity that's come up, he'll pass it on. If the market has turned wacky on us - he'll let you know if there's cause for concern and what you can do immediately to protect yourself.

He'll tell you about any interesting conversations he's had recently with Wall Street bigwigs, company insiders and other trading experts. He likes to write the Insight as if you and he are sitting down to a private dinner - and he's passing on all the best stuff he's come across in the past few days. So don't forget to include your e-mail address when you fill out your membership acceptance form. The Oxford Insight is delivered by e-mail only.

"I should write more often to tell you how well our investments are doing. Thanks to your advice... I keep telling my wife how well I'm doing for us in the stock market. I must admit she knows you guys get a lot of the credit. Thanks."
~Ernie Hinds
Members-Only Web site... Oxford Club members are busy people - and we understand that you can't always be home when important financial news is breaking. That's why every Oxford Club member receives a very important password - one to the members-only website. With this password you can gain immediate up-to-the-minute access to new recommendations, quick trades and other information vital to your wealth from anywhere in the world.

Global Investment Expeditions, Retreats and Symposiums... Perhaps no group is as adventurous as The Oxford Club. That's why we're forever traveling the world in search of new business and investment opportunities.

"I have been following your advice since last November and it has been profitable. I have learned more about asset allocation and developing a sensible attitude about risk in the past 8 months than in the previous 45 years, many of which were spent as a series 7 broker."
~Jon Major

Our travels have taken us to such places as the Caribbean, the Far East, New Zealand, Central and South America, South Africa, Iceland - and everywhere we go we make invaluable connections with leaders of industry, entrepreneurs, and heads of state. Besides all the fun, camaraderie and adventure, profits have a habit of following us. One story we like to tell is the time one of our members was so impressed with a company she visited in Hong Kong that she telephoned her broker immediately to buy it. By the time she arrived home - the stock had tripled!

Local Chapter Meetings, Where We Come To You... Last year, The Oxford Club sponsored several chapter meetings in towns and cities across America. It's one of the ways we bring the many benefits of membership to you. These events give you an opportunity to get the latest news on investments, hear experts speak about important financial matters, learn about new money-making opportunities, get asset protection advice, form strategic alliances and, of course, meet fellow members in your town. You'll find upcoming meetings listed in your twice-monthly Communiqué - and one phone call reserves your spot.

"I'm calling to thank you. My portfolio, thanks to The Oxford Club, is up over 22% year to date, and up over 252% over the last 12 months. Keep up the good work."
~ Edward Bayliss

And that's just for starters... There are literally dozens more entitlements Oxford Club members enjoy... like the annual scholarship available exclusively to members' children... Investment U - a 3-day crash course in professional investment techniques... Pillar One Partnerships, where you enjoy substantial discounts off of a host of financial services... our Members' Exchange Program, where you can connect with other members looking to partner in business deals, buy or sell real estate, arrange financing deals and more . . .

Special Offer... Join Now for as Little as $49!

No question, with all these benefits - all these opportunities to profit - you're probably thinking our special report "Payoff of a Lifetime: A Company That Fights Cancer & Terrorism Too" - and membership in The Oxford Club - must cost several thousand dollars. After all, the intelligence on this one opportunity alone is worth that. But you'll be surprised to learn that you will receive all the benefits I've mentioned here and more - for just $79. Membership regularly costs $149, but with this offer, you get nearly half off. (Or, if you prefer, you can take a trial membership for just $49 a year.)

I know this fee seems preposterously low for intelligence that can have such a profound impact on your financial life... and I don't blame you if the low price leaves you thinking, there's got to be some kind of catch... But let me assure you - there isn't. We've priced this special offer so low because we want to encourage membership, not discourage it.

So, you get everything I've mentioned to you in this letter and more, "Payoff of a Lifetime: A Company That Fights Cancer & Terrorism Too"; all our best investment recommendations; 24 twice-monthly issues of The Communiqué, the 7 wealth reports described on the membership acceptance form, access to our Clubhouses worldwide, web site and a direct line to our Members Liaison office, and the dozens of other benefits that come with The Oxford Club's "Premiere" membership.

Every week I talk to hundreds of investors who lost thousands of dollars in the grinding 3 year bear market from 2000 to 2002. You can risk that kind of money yourself in the years ahead... or you can lay those fears to rest right now. And get on with the important task of building a legacy of lasting wealth.

All the information you need is in our special report "Payoff of a Lifetime: A Company That Fights Cancer & Terrorism Too," along with the host of valuable information you'll recieve as a member of The Oxford Club. Consider it your first meaningful step toward financial independence. (And please don't forget to share this crucial intelligence with your children and grandchildren.)

You now have an opportunity to turn a small stake into a lifetime of profits. For this reason, I urge you to request and read this special report as soon as possible. You can click below to fill out your membership acceptance form online to receive the report and activate your membership right now.


James Boxley Cooke
The Oxford Club

P.S. It's only a matter of time before the national media and Wall Street realize this incredible opportunity. When that happens, millions of investors - and their fund managers will be shoveling money into this stock. Right now, you have a groundfloor investment opportunity, so don't delay. Sign up today to activate your membership. We'll e-mail you this report immediately and we'll send you a hard copy - along with all the other reports promised - via priority mail in your new member welcome package.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)

To: StockDung who wrote (940)3/22/2005 1:33:27 PM
From: Mighty_Mezz
   of 978
Hyperbole Made Easy

Whaling had its Melville, bullfighting had its Hemingway. Limitless financial opportunity has Agora Publishing, which puts out The Oxford Club and True Wealth newsletters. Nobody writes a better investment tease. The language in which riches are promised in two recent mailings from The Oxford Club and True Wealth is so ripe and over the top it's precious.
Cleans windows, too

The Oxford Club's effort begins by appropriating every investor's most ardent fantasy: a company that cures cancer and combats terrorism. In heavy-breathing, highly misleading fashion, the mailer announces that "silver bullet that conquers nature's deadliest disease is about to 'go public.'" (This stock, I later learn, "went public" more than 40 years ago.) "Now there is only a brief window -- perhaps just weeks -- before these shares blast off." It gets better. Owning this stock will be like having "a winning lottery ticket." The pitchman, Oxford chairman James Boxley Cooke, says this "may be the best single-stock idea I've seen in my lifetime as an investor." No need to compare this stock to Microsoft because, well, it's better.

Then comes the terrorism kicker. A related company technology can screen cargo at ports or airports. At any moment, says Cooke, the company could get a big contract from the Department of Homeland Security. And when it does, "the stock won't just rise. It will look like something coming off the launch pad at the Kennedy Space Center." Intrigued -- and then some -- I send for a special report on the company. I pay $49.

Then I download the report, and I'm immediately deflated. The mystery stock is Varian Medical Systems, a fine New York Stock Exchange company with revenues of $1.2 billion, making it scarcely unknown. In fact, the stock has risen 800% since January 1999. I ask Spencer Sias, Varian's head of corporate communications and investor relations, what he thinks of Oxford's pitch. "It made me wince," he says.

I ask Sias about Varian Medical's counterterrorism prospects. "I wouldn't buy our stock because of cargo screening," he says. "Right now, we have a $20-million to $25-million business selling accelerants to companies that screen cargo. We are working on a prototype of a product that would allow screening to work without disrupting the flow of trade." Revenues from that product might not show up until 2006 or 2007, if ever.
Next idea

Okay, so you pass on Varian. The mailer from True Wealth describes something that was "outlawed for 41 years -- Now LEGAL again." No, it isn't sodomy in Georgia. The investment allegedly "launched the largest family fortune the world has ever seen." This "currency" could "return 665% in the next 12 months." And then the letter goes on to make my favorite investment claim of all time: Pay to find out what the secret currency is (I'm thinking drachmas, ringgit or yak teeth) and you can then use the secret "to make as much money as you want." Could it be a printing press?

No, the "secret currency" is gold coins, which have been "legal again" for 30 years. After paying $49.50, I'm deflated once more. Saint-Gaudens gold coins, favored by True Wealth, lost almost 80% of their value after 1989. To state the obvious, when you buy gold coins, you're speculating, not investing.

Wait, there's more. The letter says subscribers will be shown a way to buy the coins at a 30% discount, "which means you could buy today and sell tomorrow -- and pocket as much as a 30% gain." Yes, if you find an incredible sucker. Simply put, the coins are sold by dealers at a discount to their "retail price." If you can then find anyone who will pay you "retail," you're golden.

Columnist Andrew Feinberg writes about the choices, challenges and frustrations facing individual investors.

Share RecommendKeepReplyMark as Last ReadRead Replies (12)

To: Mighty_Mezz who wrote (941)3/23/2005 7:09:08 PM
From: StockDung
   of 978
The Coming Dollar Crash of 2005 Could Soon Break You
...Or Make You

We'll give you the Single Biggest
Trading Opportunity of 2005
(...and a stock that will skyrocket
as the dollar dives)!

Dear Investment U Reader,

I've been watching the trend develop like a roiling storm. Despite occasional pauses, the U.S. dollar had been steadily descending. In a few months, it's expected to crash and then continue to flounder for the next five years.

Alan Greenspan warns that central banks around the world are looking to diversify their holdings away from dollars.

Warren Buffett reveals that his company now has a $12 billion bet against the dollar.

The Wall Street Journal reports "a growing fear that a declining dollar could touch off nasty side effects for stocks."

What Kind Of Profits Are We Talking About?

Investors who knew exactly what to do when the dollar declined had the opportunity to chalk up gains of 89%... 124%... and 522% in as little as three months. Between February 2003 and April 2004, one stock multiplied more than 50 times, booming 5,293%.

Just imagine - had you invested $10,000, you would have gained a nest egg of $529,300 on that single investment.

Brokers are sounding alarms up and down Wall Street. Investors are wringing their hands. But The Oxford Club sees this trend not as an epic disaster but as a historic opportunity.

Over the next few weeks, currency values are going to completely unhinge, creating the Single Biggest Trading Opportunity of 2005. (And we will show you exactly how to profit from it.)

As professional investors know, with $2 trillion dollars changing hands every day, you can make the most money when there are shifts in currency values. For example, the legendary George Soros made $1 billion in a single day in 1992 by short selling the British pound, just before the government's attempt to bolster its value predictably failed.

Now I am not suggesting that you can make money the way George Soros did. Trading currency options and futures can be very risky. Instead, I am recommending a far safer way to win BIG during the Dollar Crash.

Please understand - as the dollar falls with respect to other currencies - many U.S. stocks will indeed fall with it.

But other stocks that are denominated in certain foreign currencies will BOOM. In fact, as their currencies rise relative to the dollar, you will automatically earn huge profits even if these stocks don't go up in price!

Best of all, we will help you take advantage of this historic opportunity without undue risks or complications. You won't need a foreign broker. You won't need an overseas bank account. You won't need to make intricate option moves.

Now Is The Time To Act. The Plunging Dollar Actually Makes Certain Stocks Stronger and Safer.

By August, 2004, three of the world's top-five-performing stocks were already non-U.S. based. The U.K.'s British Energy PLC had gained 364.30%. Costa Rican-based Rica Foods, Inc. jumped 360% within a year. Bermuda's Excel Maritime Carriers rose 272.10%.

And this is happening while foreign shares are a bargain compared with U.S. equities. The S&P 500 has been expensively trading at 20 times earnings, while many overseas markets are as much as 50% cheaper on an earnings basis.

In other words, if you know where to look, and if you get in early, you can acquire foreign stocks with blockbuster potential that have minimal risk. Today, they are available at costs that are remarkably low.

But Don't Count On Your Broker To Find Them.

A recent survey revealed that not one investment advisor in 40 is even talking about the opportunity to earn big profits in stocks that are denominated in foreign currencies.

But there is good news for our Investment U readers. I am prepared to send you the names of some painstakingly researched stocks that are poised to grow explosively over the coming weeks and years.

Here Is One Stock That Promises
"Profits Of A Lifetime"...

One of the stocks we are looking at is perfectly positioned to thrive as the dollar continues to descend. Its upside potential is astronomical, and yet the company is well grounded and rock-solid.

How solid? Well, imagine a company that sells more life insurance than any other in China, a country that includes more lives than any other.

This company also sells 69% of all accident insurance in its country and is one of its largest asset managers and institutional investors, earning a piece of hundreds of billions of dollars in assets, year after year after year.

In fact, its assets are so large that they accounted for more than half of all assets under management by Chinese life insurance companies.

This company sells life insurance, annuities, and accident and health insurance policies throughout China. Currently, the company has more than 48-million individual and group insurance policies.

And that number will almost certainly rise sharply in the months ahead.

How do we know?

Because it's an $18.6-billion company with a distribution force of more than 655,000 exclusive agents operating out of approximately 8,200 field offices throughout the country. (Did I say distribution force? This is more like an army.)

In the first half of 2004, its profits reached nearly $4.7 billion. And this figure will almost certainly rise sharply in the year ahead.

You can bet that management will do a good job for us, too. After all, insiders currently own 75% of the outstanding shares.

Now Imagine Earning a 40-60% BONUS
On Top of Your "Normal" Profits

Right now, the Chinese yuan is artificially pegged to the U.S. dollar. By not allowing it to "float" and rise to its true value, the Chinese government has made its exports cheaper on the world market. But this unfair policy also keeps the Chinese people impoverished with diminished purchasing power, while enriching manufacturing tycoons and the country's political elite.

According to Jim Rogers, former partner of George Soros and probably the world's most experienced foreign stock investor, the yuan revaluation is coming. "It has to."

China has already promised to let the yuan float. And this could happen any day as the country struggles to stabilize its economy.

Now, when the yuan is freed from its artificial restriction, the Chinese stock I've been talking about could bring you substantial profits even if its price goes down! On the other hand, if the stock zooms upward as we expect, you'll make even more money. Porter Stansberry, founder of Stansberry & Associates Investment Research, estimates your yuan float bonus at 40-60%.

Don't Miss What Has Been Called "One of the Best
Investment Opportunities of the Last 50 Years"

The crash of the U.S. dollar and the inevitable rise of the Chinese yuan will supercharge certain investments with extraordinary profits.

All you need are a handful of these investments. As Investment U president, Dr. Steve Sjuggerud points out, "The way people end up getting rich is by having a few major winners... and by limiting their losses."

Welcome to a World of Wealth

My name is James Boxley Cooke. I've retired now, but I'm a former executive with T. Rowe Price, one of the oldest and most respected names in the mutual fund industry.

I'm no longer in the mutual fund business, however. But I still love showing people the shortest and most direct route to achieving great wealth.

I'm talking gains that could double your wealth each and every year for the next five years at least - without putting your wealth at undue risk.

And you not only earn spectacular returns... you actually lower your risk.

This grand trading opportunity is flying completely under the radar of most U.S. investors. Even though it is earning investors annual gains of anywhere from 146% to over 5,000% - right now... as we speak!

Best of all, the profit boom fueled by the dollar's fall is in its very early stages. There's still plenty of time left. Get in now and you stand to make a substantial sum in the near future. As I said - properly positioned in this investment strategy and you can double your money every year... and build a multi-million-dollar fortune faster than you ever thought possible!

It's a Small World... and a Profitable One!

You see, currencies are like any other commodity. They rise as demand increases and fall as demand decreases. Very soon, the demand for dollars is likely to crash. And that sets us up for the Single Biggest Trading Opportunity of 2005 - and for at least five years to follow.

Here are five reasons why many experts believe the dollar will continue to fall:

Interest rates are so low that investors in other countries can get higher yields elsewhere.

A basket of goods and services in other countries around the world generally costs less than they do here at home. That means the dollar is overvalued on the basis of purchasing power parity.

The U.S. is running a massive current account deficit. Because Americans are buying billions more in imports each month than we're exporting, the demand for dollars is waning.

The falling dollar itself is a bad omen - a self-fulfilling prophecy. Investors anywhere prefer to hold investments in a currency that is rising, not falling. When you pull up a chart of the U.S. dollar the trend is decidedly negative.

And if the dollar's falling, U.S. stocks may soon follow. That's because if the U.S. dollar falls 20%, investors have to get a 20% appreciation in U.S. dollar denominated stocks just to break even! And as demand for U.S-denominated assets weakens, down goes the dollar even further.
This may sound negative for U.S. stocks and the economy. But regardless of the impact this will have at home, it also creates a monumental investment opportunity elsewhere. But we don't want to risk our hard-earned capital on wild-and-wooly currency bets. So what do we do?

We recommend investments in the safest and highest-returning alternative to U.S. stocks - foreign shares. Not just any foreign shares, of course - only the shares of the best international companies - companies that are likely to see their local currency rise against the dollar.

But the current opportunity in foreign shares goes beyond currency advantages... which is why so many of the shares of the world's best companies are soaring higher.

As I indicated earlier, while the S&P 500 is trading at 20 times earnings... and the Nasdaq trading at 37 times earnings, many overseas markets are spectacular bargains on an earnings basis.

Investors also know that the countries, which these foreign stocks call home, are less likely to be hit by destabilizing terrorist attacks. Nobody has a grudge against Denmark or Argentina, for instance...

And then there's the growth factor.

Countries like China and India are growing four and five times as fast as the U.S. economy. And its foreign companies - not U.S. companies - who are churning out most of the goods and services to meet the soaring demand.

You Know Them, You Trust Them, You Buy Their Products... And Not Buying Their Shares Has
Cost You a Bloody Fortune!

Look around your house and what do you see...

A television set made in Japan. Dress shirts woven in Taiwan. Shoes made in Italy. Coffee from Brazil. A watch made in Switzerland.

And in your driveway? A Toyota or Nissan? Or perhaps a BMW, a Saab, or a Volkswagen?

Foreign products are everywhere.

And right now a handful of the companies who make those products - as well as the foreign companies that supply them with the raw materials and essential business services - are offering us the opportunity to get very rich.

243.8% to 967.6% gains - just this past year!

Some examples...

Investors recently pocketed 243.8% gains when South African Highveld Steel and Vanadium kept hitting record 52-week highs...

Investors in Hong Kong-based Euro Tech Holdings profited 266% as the company prepared to win contracts from the People's Republic of China...

Irish neuro-science biotech company, Elan, earned investors 273.2%...

Dutch Mittal Steel Company became the world's largest steelmaker as investors reaped 319.9% (and now it's set to gain a foothold in China)...

Novatel of Canada, a manufacturer of global positioning systems, was awarded a major contract in the Galileo Space Technology Development program. Investors blasted off to 468.5% profits...

Hong Kong's Tramford International quietly provided network security and software development as their investors were wowed by a 967.6% gain.
Some of the most profitable foreign companies are those supplying the goods and services needed to support growing economies like China and India. For instance...

Chinese resin and plastics maker Sinopec Beijing Yanhua Petrochemical surged 242% in 10 months...

Another Chinese manufacturer - Aluminum Corp. of China - has been benefiting from the global boom... up 324% in just over a year...

Eastern Europe's largest mobile phone company, Vimpelcom, rose 116.7% in less than seven months...

And shares of the Asian software developer Infosys rose an astonishing 1,154% in under a year.
But even those gains are tiny compared to the profits Luxembourg's Millicom International Cellular. That company - which supplies cellular service to developing countries - soared 5,293% in just 14 months!

But that's just a sampling of the huge gains being enjoyed by markets benefiting from burgeoning growth and the flow of money from U.S. devalued assets.

Many more are companies you know well.

United Kingdom's Rolls Royce Group has jumped 199% in less than 10 months...

Swedish cell phone giant Ericsson is up 331% on the dollar's woes in less than a year...

The British office equipment firm, Danka Business Systems, rose 492.7% in 13 months.

Consumer electronics giant Sony jumped 371% in 13 months. Its competitor, Hitachi, rose 299.7% in 15 months.
As you can see, these international companies are hardly "foreign" at all. You and others buy their products everyday.

Why These Profits Are Happening Right Now

And clearly there is money to be made in these markets. Especially now. Why?

Reason Number One; money tends to flow to international markets when the U.S. investments and the U.S. dollar are less attractive... like now.

Reason Number Two; foreign shares are breathtakingly cheap compared to U.S. stocks. Whether you're looking at sales, earnings, book value or dividends, foreign shares are a bargain compared to U.S. stocks.

Reason Number Three; all these companies are denominated in other currencies... currencies that will rise as the dollar continues to decline. That means you can make money on these investments, even if the share price stays the same - or falls slightly!

Here's what I mean:

Say you use your U.S. dollars to buy a Swiss company's stock that's denominated in Swiss francs - and the dollar declines 20% against the Swiss franc. You've made a 20% profit... even if the stock doesn't budge in price. Even if the stock price falls 10% - you're up 10% because of the currency appreciation...

That's pretty nice in itself...

But here's what's happening. More and more savvy investors are seeing this opportunity. And they're dropping their U.S. denominated investments in favor of better-valued stocks held in stronger currencies. That's driving the stock prices higher too.

These "double whammy" gains could make you very rich...

You get the benefit of the currency appreciation... and you get stock appreciation as more and more money finds its way to these once ignored and therefore vastly undervalued equities!

Add to the mix a number of global economies that are showing renewed signs of growth and prosperity and you have a recipe for outstanding profits.

Best of all, there is a way to make your move easily... with the right information.

Let me clue you in right now.

Meet the Leader of Your International Expedition

You don't have to pay big commissions to buy international companies. You're going to learn a way to buy these shares for only $5 a trade.

And you don't have to cover spreads the size of the Sears Tower. You're about to meet someone who will show you how to do an end run around them.

And you can also forget about learning German or French in your spare time to read those annual reports. You're about to ally yourself with someone who knows those reports forward and backward.

His name is Alexander Green. Currently, he's the Investment Director for The Oxford Club, a private financial fellowship of more than 60,000 members around the world.

Mr. Green is perhaps the most capable man in the U.S. to lead you on this journey. He has spent more than 15 years as a research analyst, investment advisor and registered portfolio manager for an international investment firm. He's traveled to the four corners of the planet… and has investment contacts around the globe.

Most importantly, he knows international markets like no one I've ever met. And he can smell opportunity a continent away. And his winning record on the global stage speaks for itself.

Let me give you just a few examples.

A Long History of International Gains

After the terrorist attacks in September 2001, he watched closely what happened in international markets. After all, this was an attack on the U.S. And most of the economic fallout would be at home.

He immediately recommended shares of Wal-Mart de Mexico, the largest retailer in Mexico (51% owned by Wal-Mart). Although the shares had dropped precipitously, he knew that this company was responsible for a large portion of Wal-Mart's international sales. He also knew that since the company offers a much bigger selection and better prices than any of their competitors, business was unlikely to drop off.

His recommendation played out just as he expected. And the shares soared 72.2% in just five short months.

This was hardly extraordinary. As an international money manager, Alex has been capitalizing on situations like this for almost two decades.

Clients of his were astounded, for instance, when he recommended shares of the Hong Kong Shanghai Bank (now HSBC Holdings). And they climbed more than 600% in the months that followed.

Similarly, he wrote a special report to clients of this international firm urging them to buy shares of Israeli software developer Checkpoint Software. Just before the shares rose 1,120% in a matter of months.

He has continued these good works for members of The Oxford Club.

A couple years ago he witnessed the collapse of the currency in South Africa, the rand. And he knew, then as now, where there is a crisis there must be an opportunity. As a result, he led a financial expedition to South Africa.

Sure enough, the country itself was an economic basket case, with huge social, political and economic problems. In fact, he concluded that the problems were so bad that the currency was likely to continue to cave in.

That meant exporters who took in their revenues in dollars and paid their expenses in the local rand would make a windfall on the currency exchange rates. And it was a virtual certainty those shares would fly.

So he recommended two export-oriented mining companies to capitalize on the situation.

The first was the country's largest exporter of platinum, Anglo American Platinum. Over the space of just five months, the shares rose 73%.

But his other, even safer, investment recommendation was ASA, a publicly traded fund that held only South African mining shares. Sure enough, after he recommended the fund the share price rose 129% in just 13 months. During the biggest bear market in the U.S. since The Great Depression, I might add.

He has also scored big with the world's largest food maker, the Swiss company Nestle. And with China's largest independent power producer, Huaneng Power. And with the world's largest commodity firm, Australia's BHP Billiton.

And with the fall of the dollar imminent, he recommended Oxford Club members invest in a pair of Templeton Emerging Market Funds that would benefit. And benefit they did. In 2003 alone, The Emerging Market Fund rose 88.9% and the Templeton Dragon Fund soared 101.9%.

It's no accident that some of Alex's best recommendations involved global markets. After all, over 72% of the best profit opportunities of the last 10 years have been with companies located outside U.S. borders.

By ignoring the global market place, you're missing out on three out of every four of the best stock opportunities. In fact, the most common and costly mistake American investors make is to assume the biggest profits will always be found in our own back yards... and that there's no other legitimate place to get rich.

That's simply not the case.

And not opening your eyes to all the profits the world has to offer can cost you millions in your lifetime.

But that's about to change...

Your Passport to Riches

Alexander Green, in my opinion, is arguably the very best international trading advisor in the United States. And now he's providing a unique trading service for individuals who are willing to look outside of U.S. borders... who appreciate the economic effects and realities of a declining U.S. currency... and who are looking to lock in substantial gains in a very short period of time.

It's called The International Trader Alert.

His expertise, in-depth research, and special global contacts uncover the handful of international companies that have enormous upside potential.

Easier Than You Ever Imagined!

Every recommendation is a company based outside the U.S. and denominated in another currency. He will show you exactly how you can buy these stocks through any broker.

In other words, as a subscriber, it won't take even the slightest extra effort or expense than if you purchased any U.S.-listed stock.

His updates will come at least once a week, advising you what to buy, how long to hold, and exactly when to sell, using his proprietary "laddered stops" to both protect your profits and your principal. This keeps your risk very low.

By subscribing to The International Trader Alert, you're about to learn how to become very rich in a short period of time.

Investment Bonuses for 2005…and Beyond

Not only did most markets outperform the U.S. market on a straight percentage basis in 2004, but when you add in the benefit of translating your gains back into dollars… your returns are given an additional - and often, substantial - bonus.

Investing in the S&P 500-stock index in the U.S. would have netted you under 9% this past year. Coincidentally, the Dow Jones Index of 600 European companies rose a similar amount, 9.5% in local terms but nearly double that - 18% - in dollar terms.

Investors in Austria, Europe's best-performing market, were certainly thrilled with the 55.61% increase they experienced. But for U.S. investors who switched their funds back to U.S. dollars at the end of the year, the return jumped to 67.96% - a 12.35% improvement.

South African market participants had an excellent year, gaining 28.12%. But U.S. investors who ventured into the market reaped 52.17% - another near doubling of the return - a full 24.05% better.

With the U.S. dollar still struggling and international markets so cheap, the profit potential for subscribers is greater now than ever. The exodus of wealth from U.S. denominated currencies is fueling a bull market in international company stocks like we haven't seen in decades.

The simple fact is that, when the dollar is weak, returns in most foreign currencies are enhanced when translated back to dollars.

You don't get these types of gains without many companies earning triple-digit returns - like the ones I've shown you in this letter. But what's more shocking than the profits these non-American interests generated is the fact that most U.S. investors weren't even aware of them!

What may even surprise you more is that from 1997 to 2004, U.S. markets failed to make the global top five in any year...

But how could you have known about what was happening abroad? The mainstream media - knowing the majority of its readers and viewers don't care what happens outside our borders - barely report it.

And let's face it. Your broker or financial advisor isn't equipped to give you the advice you need to take advantage of this historic opportunity.

Your Very Own Link to the Best Global Opportunities

Alex looks for "momentum-driven" stocks - stocks where revenues, earnings, and a long list of other fundamental factors are moving higher at a substantial rate - and where the growth has been consistent over several consecutive quarters. He also looks for opportunities where a company's bottom line profits will benefit from a weak U.S. dollar. And right now the waters teem with companies that do just that.

Besides the Chinese insurance company I mentioned earlier, he will give you many other investment "Shooting Stars" that could double your money in the coming year.

These 3 Shooting Stars Are Only
the Beginning of What Could Be the
Biggest Trading Opportunity of a Lifetime.

Shooting Star #1: Canadian Transportation Company on the Move

This stock has already zoomed 35% upward over the past 52 weeks, and according to our researchers, sales are likely to climb in the months ahead. For the last nine reported months, the company already posted double-digit growth in both revenues and net income. Operating margins top 32%. Best of all, earnings are expected to accelerate even more as the company gains market share and saves from lower labor costs. Before this happens, jump aboard to double your money.

Shooting Star #2: Russian Mobile Cellular Communications Giant with Connections

This company already has about 34 million subscribers. Earnings are expected to grow 25% annually for the next five years and the company is expected to report $2.75 earnings per share for 2004. Others are beginning to take notice - according to Forbes, this company has experienced one of the world's biggest jumps in "guru" holdings. To double your money, better dial in fast.

Shooting Star #3: South African Oil and Gas Group with Global Power

This group has spread to 23 other countries. It pays a nice dividend, has a low PE ratio of 14.85, and as I write this letter, its share price just hit an all-time high. Most significantly, they're involved in a giant share-for-share transaction agreement with several other companies that are expected to be approved by competition authorities in South Africa and the European Union during the first half of 2005. For you, timing could not be better for doubling your money.

Please keep in mind that these are but a few of a long list of international companies poised to reward investors with fat profits in the months and years ahead. The International Trader Alert is the only service dedicated to making sure you know about them - and that you're in them before they enjoy their biggest gains.

And Alex gives you two ways to profit. One's a conservative approach where you buy and own the stock outright. Or, if you'd prefer a more speculative play, he'll recommend a well-positioned option play when possible. That's when the profits can really mount up. For instance, Taro Pharmaceutical recently returned over 1,000% on the stock in a year. But a few well-timed option trades could have turned $5,000 into over $95,000... in about nine months!

The international markets are a proverbial gold mine of opportunity - littered with stocks like our Chinese insurance company that are on the verge of producing huge "breakout" profits for those savvy enough to strike while the iron's hot.

No wonder that, as reported in the Wall Street Journal, 75% of the new mutual fund money went to international funds in January, 2005.

That's why it is so urgent that you get on board now. The International Trader Alert features precisely the kind of fast-moving international stocks that can quickly double and triple your investment.

Here's how our service works...

As a subscriber, you will be notified by an "instant alert" as soon as Alex sees that a stock is ripe for the picking. You'll know what's driving the opportunity, what price to buy it at, how and where to buy it, when to sell it, and what the profit potential is. And if you want to speculate, he'll include an option recommendation - when and if a good opportunity presents itself.

These plays move quickly - as do the gains- so the service will be provided by e-mail or fax. You then relay the recommendation to your broker and the trade gets executed. The whole process takes a matter of minutes.

Besides the "arrive anytime" alerts you'll get a summary (also by e-mail or fax) at least once a week updating you on the current status of each recommendation.

Plus, as an International Trader Alert subscriber, you'll also get a direct access phone number to our VIP trading desk, headed by Alex's research associate, Chris Matthai. Use it anytime you have a general question about a stock we're recommending, finding a discount broker, background research, company news, or questions relating to Club services. Please understand that while we provide investment recommendations, we are not licensed by the Securities and Exchange Commission (SEC) to provide individual investment advice, and therefore, cannot address your personal circumstances.
As with other VIP services, enrollment will be conducted on a first-come, first-served basis. The cost to join The International Trader Alert is $1,250 per year - a terrific value when you consider the kinds of returns this service has produced.

Stop Anytime for a Full, Pro-Rated Refund

If you'd like to stop receiving The International Trader Alert at any time, just let us know by mail, phone or e-mail. We'll issue you a full pro-rated refund for any unused months left on your subscription.

Reserve Your Spot Today

Because we expect we'll see-an over-subscription and then a waiting list for this service, enrollment will be limited.

Let me assure you that Alex does not divulge the names of companies he is researching prior to recommending them. The effectiveness of this service is due in large part to the speed and confidentiality of the recommended trades. As editor of The International Trader Alert, his loyalty is to his subscribers.

Join us today, and Alex' next profitable recommendation could be in your hands tomorrow.

Click here to ensure a reserved spot in this remarkable trading service.

I look forward to welcoming you on board!


Chairman, Board of Governors
The Oxford Club

P.S. Please don't miss taking advantage of the historic currency upheaval that has created the Single Biggest Trading Opportunity of 2005. The Chinese life insurance stock I talked about earlier is but one of several on the cusp of enormous growth. To secure one of the remaining spots available in this service or to let us answer any questions you may have - simply click below.

Click Here to Subscribe Now

Share RecommendKeepReplyMark as Last Read
Previous 10 Next 10